132 related articles for article (PubMed ID: 12644316)
21. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
22. NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease.
Angelini DF; Zambello R; Galandrini R; Diamantini A; Placido R; Micucci F; Poccia F; Semenzato G; Borsellino G; Santoni A; Battistini L
J Leukoc Biol; 2011 Jan; 89(1):75-84. PubMed ID: 20952657
[TBL] [Abstract][Full Text] [Related]
23. Functional inhibitory human leucocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis.
Warren HS; Christiansen FT; Witt CS
Br J Haematol; 2003 Jun; 121(5):793-804. PubMed ID: 12780796
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
26. Distinct pattern of human Vdelta1 gammadelta T cells recognizing MICA.
Li J; Cui L; He W
Cell Mol Immunol; 2005 Aug; 2(4):253-8. PubMed ID: 16274622
[TBL] [Abstract][Full Text] [Related]
27. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
Ding Y; Sumitran S; Holgersson J
Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
[TBL] [Abstract][Full Text] [Related]
28. Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes.
Favier B; Espinosa E; Tabiasco J; Dos Santos C; Bonneville M; Valitutti S; Fournié JJ
J Immunol; 2003 Nov; 171(10):5027-33. PubMed ID: 14607899
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen.
Wang C; Lai AY; Baiu DC; Smith KA; Odorico JS; Wilson K; Schreiber T; de Silva S; Gumperz JE
J Immunol; 2024 Jan; 212(2):284-294. PubMed ID: 37991420
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.
Malmberg KJ; Levitsky V; Norell H; de Matos CT; Carlsten M; Schedvins K; Rabbani H; Moretta A; Söderström K; Levitskaya J; Kiessling R
J Clin Invest; 2002 Nov; 110(10):1515-23. PubMed ID: 12438449
[TBL] [Abstract][Full Text] [Related]
31. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
[TBL] [Abstract][Full Text] [Related]
32. Expression of MHC class I-related molecules MICA, HLA-E and EPCR shape endothelial cells with unique functions in innate and adaptive immunity.
Gavlovsky PJ; Tonnerre P; Guitton C; Charreau B
Hum Immunol; 2016 Nov; 77(11):1084-1091. PubMed ID: 26916837
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of Vdelta1 gammadelta T cell activation by microbial components.
Das H; Sugita M; Brenner MB
J Immunol; 2004 Jun; 172(11):6578-86. PubMed ID: 15153472
[TBL] [Abstract][Full Text] [Related]
34. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
[TBL] [Abstract][Full Text] [Related]
35. Homozygous human TAP peptide transporter mutation in HLA class I deficiency.
de la Salle H; Hanau D; Fricker D; Urlacher A; Kelly A; Salamero J; Powis SH; Donato L; Bausinger H; Laforet M
Science; 1994 Jul; 265(5169):237-41. PubMed ID: 7517574
[TBL] [Abstract][Full Text] [Related]
36. Exclusion of lipid rafts and decreased mobility of CD94/NKG2A receptors at the inhibitory NK cell synapse.
Sanni TB; Masilamani M; Kabat J; Coligan JE; Borrego F
Mol Biol Cell; 2004 Jul; 15(7):3210-23. PubMed ID: 15133125
[TBL] [Abstract][Full Text] [Related]
37. High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients.
Casado LF; Granados E; Algara P; Navarro F; Martinez-Frejo MC; López-Botet M
Haematologica; 2001 May; 86(5):457-63. PubMed ID: 11410407
[TBL] [Abstract][Full Text] [Related]
38. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
[TBL] [Abstract][Full Text] [Related]
39. Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis.
Dulphy N; Rabian C; Douay C; Flinois O; Laoussadi S; Kuipers J; Tamouza R; Charron D; Toubert A
Int Immunol; 2002 May; 14(5):471-9. PubMed ID: 11978777
[TBL] [Abstract][Full Text] [Related]
40. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]